Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 809 entries
Sorted by: Best Match Show Resources per page
Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2.

ESC heart failure

Tschirner A, Palus S, Hetzer R, Meyer R, Anker SD, Springer J.
PMID: 27668088
ESC Heart Fail. 2014 Dec;1(2):154-159. doi: 10.1002/ehf2.12017. Epub 2015 Jan 22.

BACKGROUND: Recently, it was shown that a knock-out (KO) of the polycomb histone methyltransferase Ezh2 leads to cardiac hypertrophy in mice, which was driven by the homeodomain transcription factor Six1. Here, we analyzed the expression of Six1 and its...

Cite
Tschirner A, Palus S, Hetzer R, et al. Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2. ESC Heart Fail. 2015;1(2):154-159doi: 10.1002/ehf2.12017.
Tschirner, A., Palus, S., Hetzer, R., Meyer, R., Anker, S. D., & Springer, J. (2014). Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2. ESC heart failure, 1(2), 154-159. https://doi.org/10.1002/ehf2.12017
Tschirner, Anika, et al. "Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2." ESC heart failure vol. 1,2 (2014): 154-159. doi: https://doi.org/10.1002/ehf2.12017
Tschirner A, Palus S, Hetzer R, Meyer R, Anker SD, Springer J. Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2. ESC Heart Fail. 2014 Dec;1(2):154-159. doi: 10.1002/ehf2.12017. Epub 2015 Jan 22. PMID: 27668088; PMCID: PMC5024036.
Copy Download .nbib Format: NLM
Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination.

ESC heart failure

Ahmed MB, Patel K, Fonarow GC, Morgan CJ, Butler J, Bittner V, Kulczycki A, Kheirbek RE, Aronow WS, Fletcher RD, Brown CJ, Ahmed A.
PMID: 27668089
ESC Heart Fail. 2016 Mar;3(1):11-17. doi: 10.1002/ehf2.12056. Epub 2015 Sep 21.

AIMS: Octogenarians have the highest incidence of heart failure (HF) that is not fully explained by traditional risk factors. We explored whether lack of pneumococcal vaccination is associated with higher risk of incident HF among octogenarians.METHODS AND RESULTS: In...

Cite
Ahmed MB, Patel K, Fonarow GC, et al. Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination. ESC Heart Fail. 2015;3(1):11-17doi: 10.1002/ehf2.12056.
Ahmed, M. B., Patel, K., Fonarow, G. C., Morgan, C. J., Butler, J., Bittner, V., Kulczycki, A., Kheirbek, R. E., Aronow, W. S., Fletcher, R. D., Brown, C. J., & Ahmed, A. (2016). Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination. ESC heart failure, 3(1), 11-17. https://doi.org/10.1002/ehf2.12056
Ahmed, Momanna B, et al. "Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination." ESC heart failure vol. 3,1 (2016): 11-17. doi: https://doi.org/10.1002/ehf2.12056
Ahmed MB, Patel K, Fonarow GC, Morgan CJ, Butler J, Bittner V, Kulczycki A, Kheirbek RE, Aronow WS, Fletcher RD, Brown CJ, Ahmed A. Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination. ESC Heart Fail. 2016 Mar;3(1):11-17. doi: 10.1002/ehf2.12056. Epub 2015 Sep 21. PMID: 27668089; PMCID: PMC5019269.
Copy Download .nbib Format: NLM
Palliative care in heart failure: facts and numbers.

ESC heart failure

Riley JP, Beattie JM.
PMID: 28451443
ESC Heart Fail. 2017 May;4(2):81-87. doi: 10.1002/ehf2.12125. Epub 2016 Dec 28.

Millions of people worldwide have heart failure. Despite enormous advances in care that have improved outcome, heart failure remains associated with a poor prognosis. Worldwide, there is poor short-term and long-term survival. The 1 year survival following a heart...

Cite
Riley JP, Beattie JM. Palliative care in heart failure: facts and numbers. ESC Heart Fail. 2016;4(2):81-87doi: 10.1002/ehf2.12125.
Riley, J. P., & Beattie, J. M. (2017). Palliative care in heart failure: facts and numbers. ESC heart failure, 4(2), 81-87. https://doi.org/10.1002/ehf2.12125
Riley, Jillian P, and Beattie, James M. "Palliative care in heart failure: facts and numbers." ESC heart failure vol. 4,2 (2017): 81-87. doi: https://doi.org/10.1002/ehf2.12125
Riley JP, Beattie JM. Palliative care in heart failure: facts and numbers. ESC Heart Fail. 2017 May;4(2):81-87. doi: 10.1002/ehf2.12125. Epub 2016 Dec 28. PMID: 28451443; PMCID: PMC5396035.
Copy Download .nbib Format: NLM
Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting.

ESC heart failure

Chernomordik F, Freimark D, Arad M, Shechter M, Matetzky S, Savir Y, Shlomo N, Peled A, Goldenberg I, Peled Y.
PMID: 28451448
ESC Heart Fail. 2017 May;4(2):122-129. doi: 10.1002/ehf2.12114. Epub 2016 Sep 17.

AIMS: There are limited data on the effect of low-dose, intermittent inotropic therapy in an outpatient setting on the quality of life (QOL) in patients with advanced refractory heart failure (HF) symptoms. We aimed to analyse the effect of...

Cite
Chernomordik F, Freimark D, Arad M, et al. Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting. ESC Heart Fail. 2016;4(2):122-129doi: 10.1002/ehf2.12114.
Chernomordik, F., Freimark, D., Arad, M., Shechter, M., Matetzky, S., Savir, Y., Shlomo, N., Peled, A., Goldenberg, I., & Peled, Y. (2017). Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting. ESC heart failure, 4(2), 122-129. https://doi.org/10.1002/ehf2.12114
Chernomordik, Fernando, et al. "Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting." ESC heart failure vol. 4,2 (2017): 122-129. doi: https://doi.org/10.1002/ehf2.12114
Chernomordik F, Freimark D, Arad M, Shechter M, Matetzky S, Savir Y, Shlomo N, Peled A, Goldenberg I, Peled Y. Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting. ESC Heart Fail. 2017 May;4(2):122-129. doi: 10.1002/ehf2.12114. Epub 2016 Sep 17. PMID: 28451448; PMCID: PMC5396040.
Copy Download .nbib Format: NLM
Serum albumin level and hospital mortality in acute non-ischemic heart failure.

ESC heart failure

Ancion A, Allepaerts S, Oury C, Gori AS, Piérard LA, Lancellotti P.
PMID: 28451450
ESC Heart Fail. 2017 May;4(2):138-145. doi: 10.1002/ehf2.12128. Epub 2017 Jan 13.

AIMS: Hypoalbuminemia is common in heart failure (HF), especially in elderly patients. It is associated with an increased risk of death. The present study sought to examine the prognostic significance of serum albumin level in the prediction of hospital...

Cite
Ancion A, Allepaerts S, Oury C, et al. Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC Heart Fail. 2017;4(2):138-145doi: 10.1002/ehf2.12128.
Ancion, A., Allepaerts, S., Oury, C., Gori, A. S., Piérard, L. A., & Lancellotti, P. (2017). Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC heart failure, 4(2), 138-145. https://doi.org/10.1002/ehf2.12128
Ancion, Arnaud, et al. "Serum albumin level and hospital mortality in acute non-ischemic heart failure." ESC heart failure vol. 4,2 (2017): 138-145. doi: https://doi.org/10.1002/ehf2.12128
Ancion A, Allepaerts S, Oury C, Gori AS, Piérard LA, Lancellotti P. Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC Heart Fail. 2017 May;4(2):138-145. doi: 10.1002/ehf2.12128. Epub 2017 Jan 13. PMID: 28451450; PMCID: PMC5396050.
Copy Download .nbib Format: NLM
Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation.

ESC heart failure

Schulze-Späte U, Mizani I, Salaverry KR, Chang J, Wu C, Jones M, Kennel PJ, Brunjes DL, Choo TH, Kato TS, Mancini D, Grbic J, Schulze PC.
PMID: 28451454
ESC Heart Fail. 2017 May;4(2):169-177. doi: 10.1002/ehf2.12126. Epub 2017 Mar 01.

AIMS: Heart failure (HF) is a multi-organ, pro-inflammatory syndrome that impairs bone metabolism. Pro-inflammatory cytokines and bone catabolism enhance periodontal disease, a local inflammatory, bacteria-induced disease that causes bone loss and periodontal soft tissue destruction.METHODS AND RESULTS: Medical and...

Cite
Schulze-Späte U, Mizani I, Salaverry KR, et al. Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation. ESC Heart Fail. 2017;4(2):169-177doi: 10.1002/ehf2.12126.
Schulze-Späte, U., Mizani, I., Salaverry, K. R., Chang, J., Wu, C., Jones, M., Kennel, P. J., Brunjes, D. L., Choo, T. H., Kato, T. S., Mancini, D., Grbic, J., & Schulze, P. C. (2017). Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation. ESC heart failure, 4(2), 169-177. https://doi.org/10.1002/ehf2.12126
Schulze-Späte, Ulrike, et al. "Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation." ESC heart failure vol. 4,2 (2017): 169-177. doi: https://doi.org/10.1002/ehf2.12126
Schulze-Späte U, Mizani I, Salaverry KR, Chang J, Wu C, Jones M, Kennel PJ, Brunjes DL, Choo TH, Kato TS, Mancini D, Grbic J, Schulze PC. Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation. ESC Heart Fail. 2017 May;4(2):169-177. doi: 10.1002/ehf2.12126. Epub 2017 Mar 01. PMID: 28451454; PMCID: PMC5396042.
Copy Download .nbib Format: NLM
Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure.

ESC heart failure

Clark AL, Pellicori P.
PMID: 28834633
ESC Heart Fail. 2014 Dec;1(2):82-86. doi: 10.1002/ehf2.12012. Epub 2014 Nov 24.

This article provides an overview of trials relevant to the pathophysiology, prevention, and treatment of heart failure, presented at the European Society of Cardiology meeting held in Barcelona in autumn 2014. Trials reported here include PARADIGM-HF (LCZ696 versus enalapril...

Cite
Clark AL, Pellicori P. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure. ESC Heart Fail. 2014;1(2):82-86doi: 10.1002/ehf2.12012.
Clark, A. L., & Pellicori, P. (2014). Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure. ESC heart failure, 1(2), 82-86. https://doi.org/10.1002/ehf2.12012
Clark, Andrew L, and Pellicori, Pierpaolo. "Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure." ESC heart failure vol. 1,2 (2014): 82-86. doi: https://doi.org/10.1002/ehf2.12012
Clark AL, Pellicori P. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure. ESC Heart Fail. 2014 Dec;1(2):82-86. doi: 10.1002/ehf2.12012. Epub 2014 Nov 24. PMID: 28834633.
Copy Download .nbib Format: NLM
When to increase or reduce sodium loading in the management of fluid volume status during acute decompensated heart failure.

ESC heart failure

Hirotani S, Masuyama T.
PMID: 28834634
ESC Heart Fail. 2014 Dec;1(2):75-81. doi: 10.1002/ehf2.12016. Epub 2014 Dec 03.

Sodium restriction has been believed to be indispensible to manage fluid overload during acute decompensated heart failure (ADHF). However, recently, it was reported that a change in aggression of sodium and water restriction did not affect the outcome of...

Cite
Hirotani S, Masuyama T. When to increase or reduce sodium loading in the management of fluid volume status during acute decompensated heart failure. ESC Heart Fail. 2014;1(2):75-81doi: 10.1002/ehf2.12016.
Hirotani, S., & Masuyama, T. (2014). When to increase or reduce sodium loading in the management of fluid volume status during acute decompensated heart failure. ESC heart failure, 1(2), 75-81. https://doi.org/10.1002/ehf2.12016
Hirotani, Shinichi, and Masuyama, Tohru. "When to increase or reduce sodium loading in the management of fluid volume status during acute decompensated heart failure." ESC heart failure vol. 1,2 (2014): 75-81. doi: https://doi.org/10.1002/ehf2.12016
Hirotani S, Masuyama T. When to increase or reduce sodium loading in the management of fluid volume status during acute decompensated heart failure. ESC Heart Fail. 2014 Dec;1(2):75-81. doi: 10.1002/ehf2.12016. Epub 2014 Dec 03. PMID: 28834634.
Copy Download .nbib Format: NLM
Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized, double-blind, placebo-controlled study.

ESC heart failure

Amin A, Chitsazan M, Taghavi S, Ardeshiri M.
PMID: 28834641
ESC Heart Fail. 2015 Mar;2(1):5-11. doi: 10.1002/ehf2.12025. Epub 2015 Mar 30.

OBJECTIVES: The present study assessed the changes in functional, biochemical, and echocardiographic measures following long-term liothyronine therapy in heart failure (HF) patients with low-triiodothyronine (T3) syndrome (LT3S).METHODS: In the present placebo-controlled, double-blind study, adult patients with clinically stable New...

Cite
Amin A, Chitsazan M, Taghavi S, et al. Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized, double-blind, placebo-controlled study. ESC Heart Fail. 2015;2(1):5-11doi: 10.1002/ehf2.12025.
Amin, A., Chitsazan, M., Taghavi, S., & Ardeshiri, M. (2015). Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized, double-blind, placebo-controlled study. ESC heart failure, 2(1), 5-11. https://doi.org/10.1002/ehf2.12025
Amin, Ahmad, et al. "Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized, double-blind, placebo-controlled study." ESC heart failure vol. 2,1 (2015): 5-11. doi: https://doi.org/10.1002/ehf2.12025
Amin A, Chitsazan M, Taghavi S, Ardeshiri M. Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized, double-blind, placebo-controlled study. ESC Heart Fail. 2015 Mar;2(1):5-11. doi: 10.1002/ehf2.12025. Epub 2015 Mar 30. PMID: 28834641; PMCID: PMC5746964.
Copy Download .nbib Format: NLM
Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study.

ESC heart failure

Stahrenberg R, Duvinage A, Mende M, Gelbrich G, Auf der Heide W, Düngen HD, Binder L, Nolte K, Herrmann-Lingen C, Hasenfuß G, Pieske B, Wachter R, Edelmann F.
PMID: 28834659
ESC Heart Fail. 2015 Jun;2(2):76-84. doi: 10.1002/ehf2.12034. Epub 2015 Apr 27.

OBJECTIVES AND BACKGROUND: The aim of this study was to identify determinants of submaximal exercise capacity as measured by 6 min walking distance in patients at risk for heart failure with preserved ejection fraction (HFpEF).METHODS: A cross-sectional analysis from...

Cite
Stahrenberg R, Duvinage A, Mende M, et al. Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study. ESC Heart Fail. 2015;2(2):76-84doi: 10.1002/ehf2.12034.
Stahrenberg, R., Duvinage, A., Mende, M., Gelbrich, G., Auf der Heide, W., Düngen, H. D., Binder, L., Nolte, K., Herrmann-Lingen, C., Hasenfuß, G., Pieske, B., Wachter, R., & Edelmann, F. (2015). Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study. ESC heart failure, 2(2), 76-84. https://doi.org/10.1002/ehf2.12034
Stahrenberg, Raoul, et al. "Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study." ESC heart failure vol. 2,2 (2015): 76-84. doi: https://doi.org/10.1002/ehf2.12034
Stahrenberg R, Duvinage A, Mende M, Gelbrich G, Auf der Heide W, Düngen HD, Binder L, Nolte K, Herrmann-Lingen C, Hasenfuß G, Pieske B, Wachter R, Edelmann F. Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study. ESC Heart Fail. 2015 Jun;2(2):76-84. doi: 10.1002/ehf2.12034. Epub 2015 Apr 27. PMID: 28834659; PMCID: PMC6410539.
Copy Download .nbib Format: NLM
Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival.

ESC heart failure

Jankowska EA, Tkaczyszyn M, Węgrzynowska-Teodorczyk K, Majda J, von Haehling S, Doehner W, Banasiak W, Anker SD, Ponikowski P.
PMID: 28834667
ESC Heart Fail. 2014 Sep;1(1):41-51. doi: 10.1002/ehf2.12002.

BACKGROUND: Male ageing is characterized by diminished circulating androgens with several adverse psychosomatic consequences and can be aggravated by concomitant chronic diseases. According to the European Male Aging Study (EMAS) Group, late-onset hypogonadism (LOH) refers to testosterone deficiency accompanied...

Cite
Jankowska EA, Tkaczyszyn M, Węgrzynowska-Teodorczyk K, et al. Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival. ESC Heart Fail. 2014;1(1):41-51doi: 10.1002/ehf2.12002.
Jankowska, E. A., Tkaczyszyn, M., Węgrzynowska-Teodorczyk, K., Majda, J., von Haehling, S., Doehner, W., Banasiak, W., Anker, S. D., & Ponikowski, P. (2014). Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival. ESC heart failure, 1(1), 41-51. https://doi.org/10.1002/ehf2.12002
Jankowska, Ewa A, et al. "Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival." ESC heart failure vol. 1,1 (2014): 41-51. doi: https://doi.org/10.1002/ehf2.12002
Jankowska EA, Tkaczyszyn M, Węgrzynowska-Teodorczyk K, Majda J, von Haehling S, Doehner W, Banasiak W, Anker SD, Ponikowski P. Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival. ESC Heart Fail. 2014 Sep;1(1):41-51. doi: 10.1002/ehf2.12002. PMID: 28834667.
Copy Download .nbib Format: NLM
Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure.

ESC heart failure

Anker SD, von Haehling S, Papp Z.
PMID: 28834670
ESC Heart Fail. 2014 Sep;1(1):1-3. doi: 10.1002/ehf2.12004.

No abstract available.

Cite
Anker SD, von Haehling S, Papp Z. Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure. ESC Heart Fail. 2014;1(1):1-3doi: 10.1002/ehf2.12004.
Anker, S. D., von Haehling, S., & Papp, Z. (2014). Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure. ESC heart failure, 1(1), 1-3. https://doi.org/10.1002/ehf2.12004
Anker, Stefan D, et al. "Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure." ESC heart failure vol. 1,1 (2014): 1-3. doi: https://doi.org/10.1002/ehf2.12004
Anker SD, von Haehling S, Papp Z. Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure. ESC Heart Fail. 2014 Sep;1(1):1-3. doi: 10.1002/ehf2.12004. PMID: 28834670.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 809 entries